Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Matrix metalloproteinases (MMPs) play a central role in many biological processes such as development, morphogenesis and wound healing, but their unbalanced activities are implicated in numerous disease processes such as arthritis, cancer metastasis, atherosclerosis, nephritis and fibrosis. One of the key mechanisms to control MMP activities is inhibition by endogenous inhibitors called tissue inhibitors of metalloproteinases (TIMPs). This review highlights the structures and inhibition mechanism of TIMPs, the biological activities of TIMPs, the unique properties of TIMP-3, and the altered specificity towards MMPs achieved by mutagenesis. A potential therapeutic use of TIMP variants is discussed.

Original publication

DOI

10.1186/ar573

Type

Journal article

Journal

Arthritis research

Publication Date

01/2002

Volume

4 Suppl 3

Pages

S51 - S61

Addresses

The Kennedy Institute of Rheumatology Division, Faculty of Medicine, Imperial College of Science, Technology and Medicine, London, UK. h.nagase@ic.ac.uk

Keywords

Animals, Humans, Rheumatic Diseases, Tissue Inhibitor of Metalloproteinases, Genetic Engineering, Protein Structure, Tertiary, Genetic Therapy